Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?

被引:45
作者
Becker, J. U. [1 ]
Chang, A. [2 ]
Nickeleit, V. [3 ]
Randhawa, P. [4 ]
Roufosse, C. [5 ]
机构
[1] Univ Cologne, Inst Pathol, Cologne, Germany
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ N Carolina, Div Nephropathol, Dept Pathol, Chapel Hill, NC USA
[4] Univ Pittsburgh, Dept Pathol, UPMC Montefiore, Thomas E Starzl Txn Inst, Pittsburgh, PA USA
[5] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Cellular Pathol, London, England
关键词
clinical research; practice; pathology; histopathology; kidney transplantation; nephrology; classification systems: Banff classification; guidelines; rejection: T cell mediated (TCMR); RENAL-ALLOGRAFT REJECTION; PROTOCOL BIOPSIES; TRANSPLANT RECIPIENTS; SUBCLINICAL REJECTION; WORKING CLASSIFICATION; REPRODUCIBILITY; NEPHROPATHY; CRITERIA; EXPRESSION; DIAGNOSIS;
D O I
10.1111/ajt.13784
中图分类号
R61 [外科手术学];
学科分类号
摘要
The definition of Banff Borderline became ambiguous when the Banff 2005 consensus modified the lower threshold from i1t1 (10-25% interstitial inflammation with mild tubulitis) to i0t1 (0-10% interstitial inflammation with mild tubulitis). We conducted a worldwide survey among members of the Renal Pathology Society about their approach to this diagnostic category. A web-based survey was sent out to all 503 current members (153 respondents). A database search yielded which threshold for Banff i was applied in the most influential manuscripts about Borderline. Among the 139 nephropathologists using the Borderline category, 67% use the Banff 1997 definition, requiring Banff i1. Thirty-seven percent admitted to sometimes exaggerating Banff i in the presence of tubulitis, to reach a diagnosis of Borderline. Forty-eight percent were dissatisfied with the definition of Borderline. The majority of the most influential manuscripts used the 1997 definition, contrary to the current one. There is considerable dissatisfaction with Borderline, and practice in Banff i thresholds is variable. Until additional studies inform a revision, we suggest leaving it to each pathologist's discretion whether to use i0 or i1 as the minimal threshold. In order to avoid future ambiguity, a web-based synopsis of all scattered current Banff definitions and rules should be created. The authors investigate the approach to the diagnosis of Banff borderline acute T cell-mediated rejection and find that most nephropathologists do not adhere to current Banff guidelines, but still use the old minimal threshold for tubulointerstitial infiltrates.
引用
收藏
页码:2654 / 2660
页数:7
相关论文
共 34 条
[1]   Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center [J].
Choi, BS ;
Shin, MJ ;
Shin, SJ ;
Kim, YS ;
Choi, YJ ;
Kim, YS ;
Moon, IS ;
Kim, SY ;
Koh, YB ;
Bang, BK ;
Yang, CW .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) :1354-1360
[2]  
Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930
[3]   Predicting subsequent decline in kidney allograft function from early surveillance biopsies [J].
Cosio, FG ;
Grande, JP ;
Wadei, H ;
Larson, TS ;
Griffin, MD ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) :2464-2472
[4]   Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts [J].
DElios, M ;
Josien, R ;
Manghetti, M ;
Amedei, A ;
deCarli, M ;
Cuturi, MC ;
Blancho, G ;
Buzelin, F ;
delPrete, G ;
Soulillou, JP .
KIDNEY INTERNATIONAL, 1997, 51 (06) :1876-1884
[5]   Correlation between Banff classification, acute renal rejection scores and reversal of rejection [J].
Gaber, LW ;
Moore, LW ;
Alloway, RR ;
Flax, SD ;
ShokouhAmiri, MH ;
Schroder, T ;
Gaber, AO .
KIDNEY INTERNATIONAL, 1996, 49 (02) :481-487
[6]   Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates [J].
Gibson, I. W. ;
Gwinner, W. ;
Brocker, V. ;
Sis, B. ;
Riopel, J. ;
Roberts, I. S. D. ;
Scheffner, I. ;
Jhangri, G. S. ;
Mengel, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (04) :819-825
[7]   Subclinical rejection in tacrolimus-treated renal transplant recipients [J].
Gloor, JM ;
Cohen, AJ ;
Lager, DJ ;
Grande, JP ;
Fidler, ME ;
Velosa, JA ;
Larson, TS ;
Schwab, TR ;
Griffin, MD ;
Prieto, M ;
Nyberg, SL ;
Sterioff, S ;
Kremers, WK ;
Stegall, MD .
TRANSPLANTATION, 2002, 73 (12) :1965-1968
[8]   Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts [J].
Gough, J ;
Rush, D ;
Jeffery, J ;
Nickerson, P ;
McKenna, R ;
Solez, K ;
Trpkov, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) :1081-1084
[9]   Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions [J].
Haas, M. ;
Sis, B. ;
Racusen, L. C. ;
Solez, K. ;
Glotz, D. ;
Colvin, R. B. ;
Castro, M. C. R. ;
David, D. S. R. ;
David-Neto, E. ;
Bagnasco, S. M. ;
Cendales, L. C. ;
Cornell, L. D. ;
Demetris, A. J. ;
Drachenberg, C. B. ;
Farver, C. F. ;
Farris, A. B., III ;
Gibson, I. W. ;
Kraus, E. ;
Liapis, H. ;
Loupy, A. ;
Nickeleit, V. ;
Randhawa, P. ;
Rodriguez, E. R. ;
Rush, D. ;
Smith, R. N. ;
Tan, C. D. ;
Wallace, W. D. ;
Mengel, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (02) :272-283
[10]   Risk factors for early epithelial to mesenchymal transition in renal grafts [J].
Hertig, A. ;
Verine, J. ;
Mougenot, B. ;
Jouanneau, C. ;
Ouali, N. ;
Sebe, P. ;
Glotz, D. ;
Ancel, P. -Y. ;
Rondeau, E. ;
Xu-Dubois, Y. -C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2937-2946